BE688660A - - Google Patents

Info

Publication number
BE688660A
BE688660A BE688660DA BE688660A BE 688660 A BE688660 A BE 688660A BE 688660D A BE688660D A BE 688660DA BE 688660 A BE688660 A BE 688660A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE688660A publication Critical patent/BE688660A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/50Three nitrogen atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BE688660D 1965-10-22 1966-10-21 BE688660A (pt)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
CH506368A CH478817A (de) 1965-10-22 1965-10-22 Verfahren zur Herstellung neuer N,N'-Di-(pyrimidyl-(4)-aminoalkyl)-diazacycloalkanen
CH1463065A CH478816A (de) 1965-10-22 1965-10-22 Verfahren zur Herstellung neuer N,N'-Di-(pyrimidyl-(4)-aminoalkyl)-diazacycloalkanen
CH506568A CH478819A (de) 1965-10-22 1965-10-22 Verfahren zur Herstellung neuer N,N'-Di-(pyrimidyl-(4)-aminoalkyl)-diazacycloalkanen
CH1751468A CH499528A (de) 1965-10-22 1965-10-22 Verfahren zur Herstellung neuer Pyrimidine
CH506468A CH478818A (de) 1965-10-22 1965-10-22 Verfahren zur Herstellung neuer N,N'-Di-(pyrimidyl-(4)-aminoalkyl)-diazacycloalkanen
CH1133066 1966-08-05

Publications (1)

Publication Number Publication Date
BE688660A true BE688660A (pt) 1967-04-21

Family

ID=27543760

Family Applications (1)

Application Number Title Priority Date Filing Date
BE688660D BE688660A (pt) 1965-10-22 1966-10-21

Country Status (11)

Country Link
US (1) US3503963A (pt)
BE (1) BE688660A (pt)
BR (1) BR6683919D0 (pt)
CH (5) CH478818A (pt)
DE (1) DE1670392A1 (pt)
FR (3) FR1500479A (pt)
GB (1) GB1135259A (pt)
IL (1) IL26473A (pt)
NL (1) NL6614961A (pt)
SE (1) SE345273B (pt)
SU (2) SU427513A3 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH485753A (de) * 1966-07-28 1970-02-15 Ciba Geigy Verfahren zur Herstellung neuer Aminopyrimidine
NZ540612A (en) 2003-01-14 2008-02-29 Arena Pharm Inc 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
PL378295A1 (pl) * 2003-02-24 2006-03-20 Arena Pharmaceuticals, Inc. Podstawione pochodne arylowe i heteroarylowe jako modulatory metabolizmu glukozy oraz profilaktyka i leczenie zaburzeń tego metabolizmu
AR045047A1 (es) 2003-07-11 2005-10-12 Arena Pharm Inc Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
WO2005121121A2 (en) * 2004-06-04 2005-12-22 Arena Pharmaceuticals, Inc. Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
HN2005000795A (es) * 2004-10-15 2010-08-19 Aventis Pharma Inc Pirimidinas como antagonistas del receptor de prostaglandina d2
DOP2006000010A (es) 2005-01-10 2006-07-31 Arena Pharm Inc Procedimiento para preparar eteres aromáticos
MY148521A (en) 2005-01-10 2013-04-30 Arena Pharm Inc Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
WO2007035355A2 (en) * 2005-09-16 2007-03-29 Arena Pharmaceuticals, Inc. Modulators of metabolism and the treatment of disorders related thereto
TW200811140A (en) * 2006-07-06 2008-03-01 Arena Pharm Inc Modulators of metabolism and the treatment of disorders related thereto
TW200811147A (en) * 2006-07-06 2008-03-01 Arena Pharm Inc Modulators of metabolism and the treatment of disorders related thereto
WO2011094008A1 (en) 2010-01-27 2011-08-04 Arena Pharmaceuticals, Inc. Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
EP2619198A1 (en) 2010-09-22 2013-07-31 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
EP4445956A2 (en) 2015-01-06 2024-10-16 Arena Pharmaceuticals, Inc. Compound for use in treating conditions related to the s1p1 receptor
WO2016209809A1 (en) 2015-06-22 2016-12-29 Arena Pharmaceuticals, Inc. Crystalline l-arginine salt of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl)acetic acid(compound1) for use in sipi receptor-associated disorders
WO2018151873A1 (en) 2017-02-16 2018-08-23 Arena Pharmaceuticals, Inc. Compounds and methods for treatment of primary biliary cholangitis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB944443A (pt) * 1959-09-25 1900-01-01

Also Published As

Publication number Publication date
CH499528A (de) 1970-11-30
GB1135259A (en) 1968-12-04
IL26473A (en) 1971-08-25
FR6084M (pt) 1968-06-04
CH478817A (de) 1969-09-30
CH478819A (de) 1969-09-30
BR6683919D0 (pt) 1973-12-04
US3503963A (en) 1970-03-31
SE345273B (pt) 1972-05-23
SU436494A3 (ru) 1974-07-15
CH478818A (de) 1969-09-30
NL6614961A (pt) 1967-04-24
FR1500479A (fr) 1967-11-03
SU427513A3 (ru) 1974-05-05
DE1670392A1 (de) 1970-07-16
CH478816A (de) 1969-09-30
FR6083M (pt) 1968-06-04

Similar Documents

Publication Publication Date Title
FR6083M (pt)
JPS4417977Y1 (pt)
JPS42528Y1 (pt)
JPS4213337Y1 (pt)
JPS4116525Y1 (pt)
JPS4410095Y1 (pt)
JPS4313941Y1 (pt)
JPS4833120Y1 (pt)
JPS4216453Y1 (pt)
NL6604112A (pt)
LU51342A1 (pt)
BE674699A (pt)
BE674612A (pt)
BE674593A (pt)
BE674373A (pt)
BE674328A (pt)
BE674276A (pt)
BE674051A (pt)
BE675193A (pt)
BE675196A (pt)
SE313541B (pt)
BE674906A (pt)
NL6604040A (pt)
NL6603463A (pt)
BE675007A (pt)